Lorenzo D'ambrosio - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Lorenzo D'ambrosio

This paper is made freely available by the publisher.

2022 Ramona Rotolo

ORCID

, Valeria Leuci

ORCID

, Chiara Donini

ORCID

, Federica Galvagno

ORCID

, Annamaria Massa

ORCID

, Maria Chiara De Santis

ORCID

, Serena Peirone

ORCID

, Giovanni Medico

ORCID

, Martina Sanlorenzo

ORCID

ORCID

, Loretta Gammaitoni

ORCID

, Marco Basiricò

ORCID

, Luisella Righi

ORCID

, Chiara Riganti

ORCID

, Iris Chiara Salaroglio

ORCID

and 15 other authors

Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells

Download from aacrjournals.org

This paper is made freely available by the publisher.

Erika Fiorino

ORCID

, Alessandra Merlini, Lorenzo D’Ambrosio

ORCID

, Ilaria Cerviere

ORCID

, Enrico Berrino

ORCID

, Caterina Marchiò

ORCID

, Lidia Giraudo, Marco Basiricò, Annamaria Massa, Chiara Donini

ORCID

, Valeria Leuci

ORCID

, Ramona Rotolo, Federica Galvagno

ORCID

, Letizia Vitali, Alessia Proment

ORCID

and 7 other authors

Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Bernd Kasper

ORCID

, Lorenzo D’Ambrosio

ORCID

, Elizabeth J. Davis, Matthew Ingham, Javier Martin Broto, Jonathan C. Trent, Winan J. van Houdt, Brian A. Van Tine

What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?

Upload

This paper is made freely available by the publisher.

2021 Ymera Pignochino

ORCID

, Giovanni Crisafulli

ORCID

, Giorgia Giordano, Alessandra Merlini, Enrico Berrino

ORCID

, Maria Laura Centomo, Giulia Chiabotto

ORCID

, Silvia Brusco, Marco Basiricò, Elena Maldi

ORCID

, Alberto Pisacane, Valeria Leuci

ORCID

, Dario Sangiolo

ORCID

, Lorenzo D’Ambrosio

ORCID

, Massimo Aglietta and 3 other authors

PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas—A Preclinical and Translational Study

Download from doi.org

This paper is made freely available by the publisher.

Giorgia Giordano

ORCID

, Alessandra Merlini

ORCID

, Giulio Ferrero

ORCID

, Giulia Mesiano, Erika Fiorino, Silvia Brusco, Maria Laura Centomo, Valeria Leuci

ORCID

, Lorenzo D’Ambrosio

ORCID

, Massimo Aglietta, Dario Sangiolo, Giovanni Grignani

ORCID

, Ymera Pignochino

ORCID

EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing’s Sarcoma and Chondrosarcoma

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Georgios Kantidakis

ORCID

, Saskia Litière, Anouk Neven, Marie Vinches, Ian Judson, Patrick Schöffski

ORCID

, Eva Wardelmann

ORCID

, Silvia Stacchiotti

ORCID

, Lorenzo D'Ambrosio

ORCID

, Sandrine Marréaud, Winette T. A. van der Graaf

ORCID

ORCID

, Marta Fiocco, Hans Gelderblom

ORCID

Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomas

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

M. Nannini

ORCID

, A. Rizzo, M. C. Nigro, B. Vincenzi, A. Mazzocca, G. Grignani, A. Merlini, L. D’Ambrosio

ORCID

, F. Tolomeo, G. Badalamenti, L. Incorvaia, A. Bonasera, E. Fumagalli, D. Miliziano, F. Ligorio and 5 other authors

Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world study

Upload

This paper was not found in any repository, but could be made available legally by the author.

Roberto Cannella

ORCID

, Emanuele Tabone, Giorgia Porrello, Giovanni Cappello, Cecilia Gozzo, Lorena Incorvaia, Giovanni Grignani, Alessandra Merlini, Lorenzo D’Ambrosio

ORCID

, Giuseppe Badalamenti, Daniele Regge, Tommaso Vincenzo Bartolotta

Assessment of morphological CT imaging features for the prediction of risk stratification, mutations, and prognosis of gastrointestinal stromal tumors

Upload

This paper is made freely available by the publisher.

Fabrizio Carnevale-Schianca, Daniela Caravelli, Susanna Gallo

ORCID

, Paolo Becco, Luca Paruzzo, Stefano Poletto, Alessandra Polo, Monica Mangioni, Milena Salierno, Massimo Berger, Rosanna Pessolano, Francesco Saglio, Daniela Gottardi, Delia Rota-Scalabrini, Giovanni Grignani

ORCID

and 12 other authors

Post-Transplant Cyclophosphamide and Tacrolimus—Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors

Download from doi.org

This paper is made freely available by the publisher.

2020 Javier Martin-Broto

ORCID

, Nadia Hindi, Giovanni Grignani

ORCID

, Javier Martinez-Trufero

ORCID

, Andres Redondo, Claudia Valverde, Silvia Stacchiotti, Antonio Lopez-Pousa, Lorenzo D'Ambrosio

ORCID

, Antonio Gutierrez, Herminia Perez-Vega, Victor Encinas-Tobajas, Enrique de Alava, Paola Collini, Maria Peña-Chilet and 5 other authors

Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial

Download from doi.org

This paper is made freely available by the publisher.

Emanuela Palmerini

ORCID

, Elisabetta Setola

ORCID

, Giovanni Grignani

ORCID

, Lorenzo D’Ambrosio

ORCID

, Alessandro Comandone, Alberto Righi, Alessandra Longhi, Marilena Cesari, Anna Paioli, Rossella Hakim, Michela Pierini, Emanuela Marchesi, Daniel Vanel, Ymera Pignochino

ORCID

, Davide Maria Donati and 2 other authors

High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series

Download from doi.org

This paper is made freely available by the publisher.

Valeria Leuci

ORCID

, Chiara Donini

ORCID

, Giovanni Grignani, Ramona Rotolo

ORCID

, Giulia Mesiano

ORCID

, Erika Fiorino

ORCID

, Loretta Gammaitoni

ORCID

, Lorenzo D'Ambrosio

ORCID

, Alessandra Merlini, Elisa Landoni, Enzo Medico, Sonia Capellero

ORCID

, Lidia Giraudo

ORCID

, Giulia Cattaneo, Ilenia Iaia

ORCID

and 9 other authors

CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes

Download from aacrjournals.org

This paper was not found in any repository, but could be made available legally by the author.

Lorenzo D’Ambrosio

ORCID

, Saskia Litière, Silvia Stacchiotti

ORCID

, Alessandro Gronchi

ORCID

Reply to Deleterious effect of ifosfamide in leiomyosarcoma: Convergence of weak signals

Upload

This paper was not found in any repository, but could be made available legally by the author.

Federica Grosso, Lorenzo D’Ambrosio

ORCID

, Massimo Zucchetti, Toni Ibrahim, Stefano Tamberi, Cristina Matteo, Eliana Rulli

ORCID

, Danila Comandini, Emanuela Palmerini, Giacomo Giulio Baldi, Andrea DeCensi, Marina Bergaglio, Domenico Marra, Emanuela Marchesi, Giacomo Siri and 2 other authors

Pharmacokinetics, safety, and activity of trabectedin as first‐line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US Study) from the Italian Sarcoma Group

Upload

This paper is made freely available by the publisher.

Giulia Chiabotto

ORCID

, Giovanni Grignani

ORCID

, Maja Todorovic, Valentina Martin, Maria Laura Centomo, Elisa Prola, Giorgia Giordano

ORCID

, Alessandra Merlini, Umberto Miglio

ORCID

, Enrico Berrino

ORCID

, Lucia Napione

ORCID

, Claudio Isella, Federica Capozzi, Marco Basiricò, Cristina Marsero and 6 other authors

Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular Insights

Download from doi.org

This paper is made freely available by the publisher.

Lorenzo D’Ambrosio

ORCID

, Nathan Touati, Jean‐Yves-Y. Blay, Giovanni Grignani

ORCID

, Ronan Flippot, Anna M. Czarnecka, Sophie Piperno‐Neumann, Javier Martin‐Broto, Roberta Sanfilippo, Daniela Katz, Florence Duffaud, Bruno Vincenzi, Daniel P. Stark, Filomena Mazzeo, Armin Tuchscherer and 14 other authors

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Download from api.wiley.com

This paper was not found in any repository, but could be made available legally by the author.

Giovanni Grignani

ORCID

, Alessandra Merlini, Dario Sangiolo

ORCID

, Lorenzo D'Ambrosio

ORCID

, Ymera Pignochino

ORCID

Delving into PARP inhibition from bench to bedside and back

Upload

This paper was not found in any repository, but could be made available legally by the author.

Giovanni Grignani

ORCID

, Lorenzo D'Ambrosio

ORCID

Eribulin-based treatment in patients affected by sarcomas: a case series

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2019 M. Aglietta, Lorenzo D’Ambrosio

ORCID

ORCID

Preventing venous thromboembolism in patients with cancer

Upload

This paper was not found in any repository, but could be made available legally by the author.

2018 Giovanni Grignani

ORCID

, Lorenzo D'Ambrosio

ORCID

, Ymera Pignochino

ORCID

, Emanuela Palmerini, Massimo Zucchetti, Paola Boccone, Sandra Aliberti, Silvia Stacchiotti, Rossella Bertulli, Raimondo Piana, Sara Miano, Francesco Tolomeo, Giulia Chiabotto, Dario Sangiolo

ORCID

, Alberto Pisacane and 9 other authors

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group

Upload

Missing publications? Search for publications with a matching author name.